Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis

被引：0
|
作者：
Moy, Ryan H. [1 ,2 ]
Huffman, Austin P. [2 ,3 ,4 ]
Richman, Lee P. [2 ]
Crisalli, Lisa [2 ]
Hoxie, James A. [2 ]
Vonderheide, Robert H. [2 ]
Porter, David L. [2 ]
Reshef, Ran [3 ,4 ]
机构：
[1] NewYork Presbyterian Hosp, Weill Cornell Med Coll, Dept Med, New York, NY USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Columbia Univ, Med Ctr, Dept Med, Div Hematol Oncol, New York, NY USA
[4] Columbia Univ, Med Ctr, Dept Med, Columbia Ctr Translat Immunol, New York, NY USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Chemokine receptor blockade in graft-versus-host disease
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (08): : E333 - E333
  • [22] Choosing a Regimen for Prophylaxis of Graft-versus-Host Disease
    Jong Wook Lee
    H. Joachim Deeg
    BioDrugs, 1997, 7 : 15 - 22
  • [23] Sitagliptin for Prophylaxis of Acute Graft-versus-Host Disease
    Cooper, Dennis L.
    Strair, Roger
    Jaschke, Nikolai P.
    Link-Rachner, Cornelia S.
    Rachner, Tilman D.
    Farag, Sherif S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14): : 1374 - 1376
  • [24] Choosing a regimen for prophylaxis of graft-versus-host disease
    Lee, JW
    Deeg, HJ
    BIODRUGS, 1997, 7 (01) : 15 - 22
  • [25] Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease
    S Kumar
    MG Chen
    DA Gastineau
    MA Gertz
    DJ Inwards
    MQ Lacy
    A Tefferi
    WS Harmsen
    MR Litzow
    Bone Marrow Transplantation, 2001, 27 : 1133 - 1140
  • [26] Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
    Wysocki, CA
    Burkett, SB
    Panoskaltsis-Mortari, A
    Kirby, SL
    Luster, AD
    McKinnon, K
    Blazar, BR
    Serody, JS
    JOURNAL OF IMMUNOLOGY, 2004, 173 (02): : 845 - 854
  • [27] Effect of graft leukocyte subsets with immunologic function on graft-versus-host disease
    Larocca, A
    Brizio, A
    Pioltelli, PE
    Pogliani, EM
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S98
  • [28] Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
    Kumar, S
    Chen, MG
    Gastineau, DA
    Gertz, MA
    Inwards, DJ
    Lacy, MQ
    Tefferi, A
    Harmsen, WS
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2001, 27 (11) : 1133 - 1140
  • [29] Immunologic benefits of spleen transplantation in the absence of graft-versus-host disease
    Dor, FJMF
    Cooper, DKC
    ANNALS OF SURGERY, 2006, 243 (05) : 710 - 711
  • [30] Immunologic Tolerance to Skin Allograft after Graft-versus-Host Disease
    Elias, Badwi Georges
    Meunier, Daniel I.
    Squifflet, Jean Paul
    Marot, Liliane
    Weynand, Birgit
    VanWijck, Romain R.
    Bayet, Benedicte
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2007, 119 (03) : 40E - 44E
12345